ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol

BMJ Open
December 1, 2022
Cited by 60


Related Papers

No related papers found

Powered by citation graph analysis